Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369351 | 12636935 | 1 | I | 20160801 | 20160809 | 20160809 | EXP | PHHY2016CA105950 | SANDOZ | 73.00 | YR | F | Y | 97.51000 | KG | 20160809 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126369351 | 12636935 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | U | 75985 | 500 | MG | FILM-COATED TABLET | BID | |||||
| 126369351 | 12636935 | 2 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 126369351 | 12636935 | 3 | C | AVAPRO | IRBESARTAN | 1 | Unknown | U | 0 | TABLET | |||||||||
| 126369351 | 12636935 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | TABLET | |||||||||
| 126369351 | 12636935 | 5 | C | CADUET | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | TABLET | |||||||||
| 126369351 | 12636935 | 6 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 126369351 | 12636935 | 7 | C | ELTROXIN | LEVOTHYROXINE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 126369351 | 12636935 | 8 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126369351 | 12636935 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | U | 0 | CAPSULE | |||||||||
| 126369351 | 12636935 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126369351 | 12636935 | 1 | Type 2 diabetes mellitus |
| 126369351 | 12636935 | 2 | Product used for unknown indication |
| 126369351 | 12636935 | 3 | Product used for unknown indication |
| 126369351 | 12636935 | 4 | Product used for unknown indication |
| 126369351 | 12636935 | 5 | Product used for unknown indication |
| 126369351 | 12636935 | 6 | Product used for unknown indication |
| 126369351 | 12636935 | 7 | Product used for unknown indication |
| 126369351 | 12636935 | 8 | Product used for unknown indication |
| 126369351 | 12636935 | 9 | Product used for unknown indication |
| 126369351 | 12636935 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126369351 | 12636935 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126369351 | 12636935 | Blood glucose decreased | |
| 126369351 | 12636935 | Frequent bowel movements | |
| 126369351 | 12636935 | Nausea | |
| 126369351 | 12636935 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |